We invest in early-stage startups led by exceptional entrepreneurs. Our sweet spots are computational biology and drug development and delivery. Our seed investments are around $1m, and we do follow-on investments. Our highly versatile and experienced team provides entrepreneurs with extensive mentoring and networking support. Our experience and know-how, combined with our financial backing and administrative assistance, give early-stage startups all the tools they need to grow and thrive.
| Website | http://www.vlx.co.il |
| Revenue | $5.8 million |
| Employees | 10 (6 on RocketReach) |
| Founded | 2013 |
| Address | PO Box 39158, Jerusalem, Jerusalem, IL |
| Phone | +972 2-566-1881 |
| Technologies |
JavaScript
,
HTML
,
PHP
+13 more
(view full list)
|
| Industry | Venture Capital and Private Equity Principals, Finance General, Finance |
| Web Rank | 9 Million |
| Keywords | Venture Capital, Seed Funding, Startups, Investment, Early Stage Investing, Computational Biology, Biotechnology, Life Sciences, Biotech Investing, Entrepreneurs, Drug Discovery, Drug Delivery, Seed Round, Biopharma, Pharmaceutical, Healthcare Investing, Series A, Health Tech |
| Competitors | Sequoia Capital, Benchmark, Accel in India, Andreessen Horowitz, Bessemer Venture Partners, Kleiner Perkins, Greylock, Index Ventures, Insight Partners, Lightspeed +34 more (view full list) |
| SIC | SIC Code 679 Companies, SIC Code 67 Companies |
| NAICS | NAICS Code 52 Companies, NAICS Code 523 Companies, NAICS Code 5239 Companies |
Looking for a particular VLX Ventures employee's phone or email?
The VLX Ventures annual revenue was $5.8 million in 2026.
Eli Sorzon is the CFO of VLX Ventures.
6 people are employed at VLX Ventures.
VLX Ventures is based in Jerusalem, Jerusalem.
The NAICS codes for VLX Ventures are [52, 523, 5239].
The SIC codes for VLX Ventures are [679, 67].